Pro-Dex, Inc.

PDEX Healthcare Medical Instruments & Supplies

Pro-Dex, Inc.’s revenue for fiscal 2026 (year ended June 2026) was $77.5 million, up 16.5% from fiscal 2025. In the quarter to June 2026, revenue grew 16.7%, EPS grew 143.2%, free cash flow fell 79.0% and total debt rose 43.5%, each against the same quarter a year earlier. Revenue growth for ten consecutive years.

58.26 1.76 −2.93%
Market cap
$194.1M
P/E
13.8×
Fwd P/E
23.5×
Dividend yield
—
F-score
6/9
Altman Z
7.38
Beneish M
−1.11
Dividend safety
n/a
Older periods Sep '25 Dec '25 Mar '26 Jun '26
P/E ratio

+8 more quarters

9.87 11.09 13.28 13.84
P/S ratio
1.57 1.73 2.11 2.44
P/FCF ratio
0.00 20.88 22.67 28.08
P/Operating CF
47.80 35.00 96.28 (691.88)
P/B ratio
2.66 3.00 3.48 3.97
EV/Sales
1.54 1.72 2.15 2.49
EV/EBITDA
9.01 9.86 13.26 13.39
EV/FCF
(49.20) 20.74 23.15 28.67
Current Ratio
3.73 4.03 3.67 4.10
Net Debt/EBITDA
(0.56) (0.23) 0.96 1.00
Debt/Equity
0.21 0.19 0.32 0.28
Earnings Yield
10.13% 9.02% 7.53% 7.22%
Free Cash Flow Yield
(2.00%) 4.79% 4.41% 3.56%
Free Cash Flow per Share
0.68 1.08 0.48 (0.15)
Book value per Share
12.73 12.81 14.12 14.77
Free Cash Flow
2.21 3.50 1.52 (0.48)
EV/EBIT
10.06 10.94 14.86 14.84
Other line items

Show all line items

Columns are period end dates